StockWatch
·

Nath Bio-Genes (India) Ltd Q2 FY27 Results

NATHBIOGENQ2 FY27 Results
Filing
Result:Poor#Margin squeeze
MetricValue (₹ Cr)Q1 FY27Q2 FY26
Revenue40.7487.6%7.1%
Total Income42.5887.1%7.0%
Expenditure43.0885.6%1.6%
PBT1.3196.0%75.9%
Net Profit0.4298.7%84.8%
OPM15.83%4.76pp2.80pp
NPM0.98%8.79pp5.03pp
EPS0.2298.7%84.3%
View full financials

Revenue fell 7.1% YoY and margins compressed sharply (OPM 18.6%→15.8%, NPM 6.0%→1.0%), driving an 84.8% PAT decline that signals clear deterioration rather than a one-off blip.

Informational and educational content only. Not investment advice.